References
- Anderson A. B. M., Haynes P. J., Guillebaud J., Turnbull A. C. Reduction of menstrual blood loss by prostaglandin synthetase inhibitors. Lancet 1976; i: 774
- Casslén B. Proteinases and proteinase inhibitors in uterine fluid with special reference to IUD-users. Acta Obstet Gynecol Scand Suppl 1981; 98
- Guillebaud J., Turnbull A. C. Treatment with a prostaglandin inhibitor of excessive menstrual bleeding with intrauterine contraceptive devices (IUDs). Res Clin Forums 1979; 1: 103
- Hallberg L., Högdahl A.-M., Nilsson L., Rybo G. Menstrual blood loss. A population study. Acta Obstet Gynecol Scand 1966; 45: 320
- Hallberg L., Nilsson L. Determination of menstrual blood loss. Scand J Clin Lab Invest 1964; 16: 244
- Hillier K., Kasonde J. M. Prostaglandin E and F concentrations in human endometrium after insertion of intrauterine contraceptive device. Lancet 1976; i: 15
- Nilsson L., Rybo G. Treatment of menorrhagia. Am J Obstet Gynecol 1971; 110: 713
- Rybo G. IUDs and endometrial bleeding: Qualitative and quantitative aspects. IUD Pathology and Management, E. S. E. Hafez, W. A. A. van Os. MTP Press, Lancaster 1980; vol. 3: 63
- Toppozada M. Prostaglandins and their synthesis inhibitors in dysfunctional uterine bleeding. Practical Applications of Prostaglandins and Their Synthesis Inhibitors, M. M. Karim. MTP Press, Lancaster 1979; 238
- Willman E. A., Collins W. P., Clayton S. G. Studies in the involvement of prostaglandins in uterine symptomatology and pathology. Br J Obstet Gynaecol 1976; 83: 337